Specific Systems of Treatment
finally once every fourth day for three weeks. Following that, 5-15 drops in solution per week is a good maintenance dosage. But the type of diet will affect this.
Yet another method is to take 3 to 4 drops of hydrogen peroxide in an aloe vera mixture, instead of in straight water.
Patients who cannot reach a therapeutic dosage, because of nausea, do best to be given intravenous doses. The present writer does not have data on the dosages.
A stinging or burning sensation may occur at times, when an injection is given. But it is said to be transitory and harmless, and can be helped by slowing the rate of infusion. Application of Pain Gel, which contains 10% dimethyl sulfoxide (DMSO, an inflammatory compound), topically to the surface of the injection also helps reduce irri- tation to the vein.
markable adjunct to other cancer treatments, but is only avail- able at a few alternate cancer clinics.
Dr. Douglass has publicized a little-known method of treating cancer, called Photolumines- cence, which is inexpensive, painless, and only requires about half an hour per treatment.
As the patient lies on a table, some of his blood is run into a quartz tube which is irradiated with ultraviolet light. Each treatment irradiates about 10% of his blood.
This treatment has been used on cancer pa- tients and, in Africa, on hundreds of AIDS patients.
Because the process is simple and cannot be patented, organized medicine and the pharmaceu- tical industry are not interested in the procedure.
____________________ STANISLAW BURZYNSKI, M.D., 1980s
A paper published by the Grotz group, says that the peroxide remedy may produce “skin erup- tions, nausea, headaches, sleepiness, unusual fa- tigue, diarrhea, head or chest colds, ear infections, boils, or other ways the body uses to loosen tox- ins. This is a natural cleansing of the body” (Hy- drogen Peroxide Therapy, 28).
In summary: There are few side effects with hydrogen peroxide therapy. In rare cases, a prob- lem involving inflammation of veins at the site of injection will occur. Hydrogen peroxide should not be taken orally, as it causes nausea and vomiting; and rectal administration can lead to inflammation of the lower intestinal tract. Other side effects observed include tem- porary faintness, fatigue, headaches, and chest pain.
Most peroxide problems stem from the use of either an inappropriate administration route, administration above patient tolerance, the mix- ing of oxidative chemicals with other sub- stances, or using oxidative chemicals in too great a concentration.
Sources for hydrogen peroxide—Interna- tional Bio-Oxidative Medicine Foundation, P.O. Box 13205, Oklahoma City, OK 73113-1205 Ph: (405) 478-4266, or / Hospital Santa Monica, 4100 Bonita Road, Bonita, CA 91910 Ph: (800) 359-6547 / (619) 428-1147
WILLIAM CAMPBELL DOUGLASS, M.D., 1980s
Note to researchers: The possibilities here are remarkable. It would be well if double-blind tests were performed, to verify the usefulness of this procedure.
Working Summary: Photoluminescence therapy is a re-
Note to researchers: Burzynski’s short-chain BDS amino acids should be applied in carefully controlled oral and intrave- nous experiments on animals, followed by tests on humans.
Working Summary: Burzynski’s amino acids treatment may have some relation to Burton’s four blood protein treatment. Both therapies are still being given today. As usual with most therapies, no change in diet or lifestyle is required, so it is less likely to provide long-term remission.
You will recall earlier mention of J.H. Law- rence, Ph.D., a British scientist during World War II, who claimed that something in urine seemed to have anti-tumor activity in animals.
Then there was Dr. Danopoulos, who, in the 1950s, discovered that purified urea could help reduce cancer masses.
Stanislaw R. Burzynski, M.D., Ph.D., expanded on this theory of urine derivatives; and, in the 1980s, he theorized that certain substances could inhibit the growth of tumor cells, without dis- turbing normal cells. After isolating them from human urine, he is said to have later synthe- sized these compounds in the laboratory.
A graduate of the Lublin Medical Academy in Poland, his treatment is based on the theory that the body has a parallel biochemical defense system independent of the immune system. He calls it the biochemical defense system (BDS), and says it is completely different than in the immune system.
“It is a reprogramming of defective cells. It’s no longer killing of the cells, but changing the program inside the defective cell, which means that the cell will begin functioning normally.”— Stanislaw Burzynski, ”Antineoplastons,” Lec- ture delivered at World Foundation Research Congress, October 7, 1990.
Burzynski found that the BDS consisted of short-chain amino acids, known as polypep-